One Stop Shop for All Your Market Research Reports

Global Psoriasis Therapeutics Market Threats, Analysis, Key Players, Growth, and Forecast 2026

Unknown psoriasis disease etiology expected to hamper growth of global market. Psoriasis is a non-contagious autoimmune skin disease characterized by red scaly patches forming on the affected area. This condition causes skin cells to grow fast and cause rapid buildup of thick scaly patches on the surface of skin. Moreover, skin cells cycle is disturbed, due to which new cells under the skin grow and surface quickly to form itchy patches known as "plaques". Symptoms worsen during winter season, and sufferers can experience allergic reactions to medicines, infections or even psychological stress. Diagnosis of psoriasis is typically based on signs and symptoms. Patches can form on the scalp, neck, anywhere on the feet and hands, especially on knees, palms, and elbows. Psoriasis occurs mostly in adults; however, it can also be seen in children and adolescents. Generally, it was thought to be a genetic disease triggered by pollution. Etiology of this disease is unknown; however, it is said that overactivity of the immune system can cause widespread inflammation, thereby resulting in flaking of skin and forming red, white or silvery patches. Rising prevalence of psoriasis patients, growing unmet needs in terms of availability of appropriate medicines, and launch of novel pipeline drugs in future are factors driving growth of the global psoriasis therapeutics market. In addition, government initiatives for research and development (R&D) of the disease and cures, and favorable reimbursement policies will further fuel growth of this market over the forecast period. However, unknown etiology of this disease is the major factor hampering growth of the market. Currently, the market in North America dominates the global psoriasis therapeutics market in revenue terms owing to higher psoriasis patient population pool, emergence of novel therapies, and favorable government reimbursement policies in countries in the region. Europe is currently the second-largest market due to increasing number of sufferers seeking treatment for the disease. The market in Asia Pacific is expected to witness relatively high growth over the forecast period owing to rising awareness regarding the disease and increasing government funding for R&D. Among the route of administration segments, the topical segment accounts for largest revenue share owing to its effectiveness, safety, and efficient drug delivery method. In addition, the parenteral segment is expected to witness significant growth during the forecast period owing to rising preference given to newly approved biologics to treat severe psoriasis. Among the distribution channel segments, the hospital pharmacy segment plays accounts for major revenue share, followed by retail pharmacy and online sales. Interleukin blockers segment is expected to be the most attractive segment among the other products segment, owing to its increasing usage and its ability to act on target proteins. Market Segmentation: Global market segmentation by product:
  • TNF Inhibitors
  • PDE4 Inhibitors
  • Interleukin Blockers
  • Others
Global market segmentation by therapy:
  • Topical Therapeutic Drugs
  • Systemic Therapeutic Drugs
  • Combinations
  • Others
Global market segmentation by treatment molecule type:
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Sales
  • Others
Global market segmentation by route of administration:
  • Oral
  • Parental
  • Topical
Key players:
  • Abbvie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Bristol Myers Squibb Co.
  • Celgene Corp.
  • Eisai Co. Ltd.
  • Eli Lilly and Co.
  • GlaxoSmithKline plc
  • Incyte Corp.
  • Isotechnika Inc.
  • Janssen Biotech Inc.
  • LEO Pharma A/S
  • Merck & Co. Inc.
  • Novartis International AG
  • Pfizer Inc.
  • UCB S.A
Report Structure: In the first section of the report we offer a table of content, followed by a list of figures. The next section offers a definition and brief explanation of the various products and segmentation of the target market, along with research methodology and a list of acronyms and sources used to gather and analyze data and information. The third section of the report entails a brief list of drivers, restraints, opportunities, and threats (DROTs) in the target market. The report also offers insights on various trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet and others. The final section comprises detailed profiles of key players in the target market and a SWOT analysis of each company, apart from strategies, acquisitions and mergers. Objective of Report: Sections of the report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and revenue (US$ Mn/Bn) estimation and projection, Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the target product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key finding for markets in regions and countries. This report is valuable asset for the existing players, new entrants and the future investors. Who we are and what we do: Market.biz is a pioneering company in the fields of market research and analytical reporting. Our services enable clients to enhance business efficiency and focus on other core aspects of operations, while we take care of market research and reporting needs. Market.biz conducts and executes detailed and in-depth research and analysis across all relevant domains and offers accurate and insightful estimations and forecasts to enable clients to take well-informed and crucial decisions in their respective industries, sectors, or companies. Market.biz has access to the world’s most comprehensive and up-to-date databases in any business sector, as we understand the specific and varying needs of our clients. We offer updated reports to keep up with the changing scenarios in global markets and strive to ensure that only the utmost quality is established and maintained in every single report we produce. Our reports are conveniently designed and structured and are visually-pleasing. We provide a detailed analysis outlook of competitive markets and identify and study new and emerging trends and other crucial aspects and factors impacting or driving market growth. We also offer insights regarding new and emerging opportunities in the market and present the information in a comprehensive report focused on your respective market or sector.
Request for Table of Contents

Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ $ 4395
Multi User US $6395
Corporate User US $9395
About this Report
Report ID 148413
Category
  • Pharmaceuticals and Healthcare
Published on Upcoming
Number of Pages NA
Publisher Name Prudour
Editor Rating
★★★★★
★★★★★
(0)